TaiDoc Technology Corporation (TPE:4736)
Taiwan · Delayed Price · Currency is TWD 124.00
+0.50 (0.40%)
Dec 3, 2025, 1:30 PM CST
TaiDoc Technology Revenue
TaiDoc Technology had revenue of 1.08B TWD in the quarter ending September 30, 2025, a decrease of -12.50%. This brings the company's revenue in the last twelve months to 4.34B, down -4.60% year-over-year. In the year 2024, TaiDoc Technology had annual revenue of 4.64B, down -3.46%.
Revenue (ttm)
4.34B
Revenue Growth
-4.60%
P/S Ratio
2.71
Revenue / Employee
6.64M
Employees
654
Market Cap
11.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.64B | -166.10M | -3.46% |
| Dec 31, 2023 | 4.81B | -4.82B | -50.07% |
| Dec 31, 2022 | 9.63B | 3.13B | 48.26% |
| Dec 31, 2021 | 6.49B | 589.73M | 9.99% |
| Dec 31, 2020 | 5.90B | 1.77B | 42.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |